| Drug Name: | Reproterol hydrochloride (13055-82-8) |
|---|---|
| PubChem ID: | 3032600 |
| SMILES: | CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O.Cl |
| InchiKey: | XSFWDHONRBZVEJ-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 425.873 |
| LogP | : | -0.02 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 10 |
| Hydrogen Bond Donor Count | : | 4 |
| Total Polar Surface Area | : | 134.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Desensitization Cardiovascular Effects | Beta-2 adrenergic receptor (P07550) | Bronchodilatation@ susceptibility to aGOnist-induced desensitization@cardiovascular effects [ ADR Type 1 ] | Beta2-adrenergic receptor genetics |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|